Statistics

Total Visits

Views
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial 183

Total Visits per Month

May 2020 June 2020 July 2020 August 2020 September 2020 October 2020 November 2020
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial 0 2 0 0 0 0 0

File Downloads

Views

Top Country Views

Views
United States 43
Australia 9
China 9
Germany 7

Top City Views

Views
Ashburn 10
Fairfield 10
Mountain View 9
Kaleen 7
Beijing 4
Nürnberg 2
Seattle 2
Adelaide 1
Bondi 1
Cambridge 1